The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2 - Metastatic Breast Cancer Patients
e-ESO Podcasts - Een podcast door ESO - European School of Oncology
Categorieën:
Eman Aboelkheir, Alexandria University, Alexandria, Egypt
